Literature DB >> 29438460

Practical Dietary Recommendations for the Prevention and Management of Nonalcoholic Fatty Liver Disease in Adults.

Elena S George1,2, Adrienne Forsyth1, Catherine Itsiopoulos1, Amanda J Nicoll3, Marno Ryan4, Siddharth Sood5, Stuart K Roberts6, Audrey C Tierney1,2.   

Abstract

Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide. In the absence of effective pharmacotherapies, clinical guidelines focus primarily on weight loss to treat this condition. Established consensus, evidence-based, and clinical dietary recommendations for NAFLD are currently lacking. The aim of this paper is to provide evidence-based practical dietary recommendations for the prevention and management of NAFLD in adults. A literature review focusing on established principles for the development of clinical practice recommendations was employed using the following criteria: based on substantial evidence, ensures risk minimization, is flexible for an individual patient approach, and is open to further modification as evidence emerges. The Practice-based Evidence in Nutrition classification system was used to grade these principles. Five key dietary recommendations were developed: 1) follow traditional dietary patterns, such as the Mediterranean diet; 2) limit excess fructose consumption and avoid processed foods and beverages with added fructose; 3) PUFAs, especially long-chain omega-3 rich foods and MUFAs, should replace SFAs in the diet; 4) replace processed food, fast food, commercial bakery goods, and sweets with unprocessed foods high in fiber, including whole grains, vegetables, fruits, legumes, nuts, and seeds; and 5) avoid excess alcohol consumption. Improving diet quality may reduce the incidence and progression of NAFLD and associated risk factors. Many of the benefits are likely to result from the collective effect of dietary patterns. High-quality research-in particular, randomized clinical trials assessing dietary interventions that focus on liver-specific endpoints-are needed as a priority.
© 2018 American Society for Nutrition. All rights reserved.

Entities:  

Keywords:  clinical guidelines; diet; dietary recommendations; nonalcoholic fatty liver disease; nonalcoholic steatohepatitis

Mesh:

Substances:

Year:  2018        PMID: 29438460      PMCID: PMC6333937          DOI: 10.1093/advances/nmx007

Source DB:  PubMed          Journal:  Adv Nutr        ISSN: 2161-8313            Impact factor:   8.701


  112 in total

1.  Adherence to the Dietary Approaches to Stop Hypertension (DASH) and risk of Nonalcoholic Fatty Liver Disease.

Authors:  Azita Hekmatdoost; Ali Shamsipour; Mohammad Meibodi; Newsha Gheibizadeh; Tannaz Eslamparast; Hossein Poustchi
Journal:  Int J Food Sci Nutr       Date:  2016-07-19       Impact factor: 3.833

2.  Flaxseed oil supplementation does not affect plasma lipoprotein concentration or particle size in human subjects.

Authors:  Charles R Harper; Megan C Edwards; Terry A Jacobson
Journal:  J Nutr       Date:  2006-11       Impact factor: 4.798

3.  Pro12Ala polymorphism of the PPARG2 gene is associated with type 2 diabetes mellitus and peripheral insulin sensitivity in a population with a high intake of oleic acid.

Authors:  Federico Soriguer; Sonsoles Morcillo; Fernando Cardona; Gemma Rojo-Martínez; María de la Cruz Almaráz; María de la Soledad Ruiz de Adana; Gabriel Olveira; Francisco Tinahones; Isabel Esteva
Journal:  J Nutr       Date:  2006-09       Impact factor: 4.798

4.  Mediterranean diet and non-alcoholic fatty liver disease: the need of extended and comprehensive interventions.

Authors:  Francesca M Trovato; Daniela Catalano; G Fabio Martines; Patrizia Pace; Guglielmo M Trovato
Journal:  Clin Nutr       Date:  2014-01-31       Impact factor: 7.324

5.  Habitual coffee but not green tea consumption is inversely associated with metabolic syndrome: an epidemiological study in a general Japanese population.

Authors:  Asuka Hino; Hisashi Adachi; Mika Enomoto; Kumiko Furuki; Yoshiyuki Shigetoh; Maki Ohtsuka; Shun-Ichi Kumagae; Yuji Hirai; Ali Jalaldin; Akira Satoh; Tsutomu Imaizumi
Journal:  Diabetes Res Clin Pract       Date:  2006-10-30       Impact factor: 5.602

6.  Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease.

Authors:  Mattias Ekstedt; Lennart E Franzén; Marika Holmqvist; Preben Bendtsen; Ulrik L Mathiesen; Göran Bodemar; Stergios Kechagias
Journal:  Scand J Gastroenterol       Date:  2009       Impact factor: 2.423

7.  The effects of DASH diet on weight loss and metabolic status in adults with non-alcoholic fatty liver disease: a randomized clinical trial.

Authors:  Mohsen Razavi Zade; Mohammad Hosein Telkabadi; Fereshteh Bahmani; Behnaz Salehi; Shima Farshbaf; Zatollah Asemi
Journal:  Liver Int       Date:  2015-11-18       Impact factor: 5.828

8.  Dietary fructose reduction improves markers of cardiovascular disease risk in Hispanic-American adolescents with NAFLD.

Authors:  Ran Jin; Jean A Welsh; Ngoc-Anh Le; Jeffrey Holzberg; Puneet Sharma; Diego R Martin; Miriam B Vos
Journal:  Nutrients       Date:  2014-08-08       Impact factor: 5.717

9.  Fast-food-based hyper-alimentation can induce rapid and profound elevation of serum alanine aminotransferase in healthy subjects.

Authors:  S Kechagias; A Ernersson; O Dahlqvist; P Lundberg; T Lindström; F H Nystrom
Journal:  Gut       Date:  2008-02-14       Impact factor: 23.059

10.  Hepatic adverse effects of fructose consumption independent of overweight/obesity.

Authors:  Alini Schultz; Debora Neil; Marcia B Aguila; Carlos A Mandarim-de-Lacerda
Journal:  Int J Mol Sci       Date:  2013-11-05       Impact factor: 5.923

View more
  29 in total

Review 1.  Nuts and Cardiovascular Disease Prevention.

Authors:  A M Coates; A M Hill; S Y Tan
Journal:  Curr Atheroscler Rep       Date:  2018-08-09       Impact factor: 5.113

2.  Synergism of Adipocytokine Profile and ADIPOQ/TNF-α Polymorphisms in NAFLD-associated MetS Predict Colorectal Liver Metastases Outgrowth.

Authors:  Rosa Divella; Antonella Daniele; Raffaele DE Luca; Antonio Mazzocca; Eustachio Ruggieri; Eufemia Savino; Porzia Casamassima; Michele Simone; Carlo Sabba; Angelo Paradiso
Journal:  Cancer Genomics Proteomics       Date:  2019 Nov-Dec       Impact factor: 4.069

Review 3.  Mitochondrial dysfunction in nonalcoholic fatty liver disease and alcohol related liver disease.

Authors:  Pankaj Prasun; Ilona Ginevic; Kimihiko Oishi
Journal:  Transl Gastroenterol Hepatol       Date:  2021-01-05

4.  The effect of sesame oil consumption compared to sunflower oil on lipid profile, blood pressure, and anthropometric indices in women with non-alcoholic fatty liver disease: a randomized double-blind controlled trial.

Authors:  Hamid Vahedi; Masoumeh Atefi; Mohammad Hassan Entezari; Akbar Hassanzadeh
Journal:  Trials       Date:  2022-07-08       Impact factor: 2.728

5.  Exploring the Path of Mediterranean Diet, Non-Alcoholic Fatty Liver Disease (NAFLD) and Inflammation towards 10-Year Cardiovascular Disease (CVD) Risk: The ATTICA Study 10-Year Follow-Up (2002-2012).

Authors:  Elena S George; Ekavi N Georgousopoulou; Duane D Mellor; Christina Chrysohoou; Christos Pitsavos; Demosthenes B Panagiotakos
Journal:  Nutrients       Date:  2022-06-07       Impact factor: 6.706

Review 6.  Overview of Non-Alcoholic Fatty Liver Disease (NAFLD) and the Role of Sugary Food Consumption and Other Dietary Components in Its Development.

Authors:  Pau Vancells Lujan; Esther Viñas Esmel; Emilio Sacanella Meseguer
Journal:  Nutrients       Date:  2021-04-24       Impact factor: 5.717

7.  Self-Rated Diet Quality and Cardiometabolic Health Among U.S. Adults, 2011-2018.

Authors:  Valerie K Sullivan; Emily A Johnston; Melanie J Firestone; Stella S Yi; Jeannette M Beasley
Journal:  Am J Prev Med       Date:  2021-07-08       Impact factor: 6.604

Review 8.  The Significance of the Mediterranean Diet in the Management of Non-Alcoholic Fatty Liver Disease: A Systematic Review.

Authors:  Harpreet Gosal; Harsimran Kaur; Hyginus Chakwop Ngassa; Khaled A Elmenawi; Vishwanath Anil; Lubna Mohammed
Journal:  Cureus       Date:  2021-06-13

9.  A nomogram incorporated lifestyle indicators for predicting nonalcoholic fatty liver disease.

Authors:  Kaili Peng; Shuofan Wang; Linjiao Gao; Huaqiang You
Journal:  Medicine (Baltimore)       Date:  2021-07-02       Impact factor: 1.817

Review 10.  Artificial sweeteners are related to non-alcoholic fatty liver disease: Microbiota dysbiosis as a novel potential mechanism.

Authors:  Hadi Emamat; Hamid Ghalandari; Hadith Tangestani; Afsoun Abdollahi; Azita Hekmatdoost
Journal:  EXCLI J       Date:  2020-05-12       Impact factor: 4.068

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.